Intellipharmaceutics Announces Third Quarter 2018 Results
(WorldNews Canada)

TORONTO, ON / ACCESSWIRE / October 15, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI; TSX: IPCI) (`Intellipharmaceutics` or the `Company`), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and nine months ended August 31, 2018. All dollar amounts referenced herein are in United States dollars unless otherwise noted. Third Quarter 2018 Highlights `We made great progress with respect to our development programs in the third quarter, despite challenging financial circumstances,` said Dr. Isa Odidi, CEO of...